Target intelligence / Profile preview

Fascia

Molecular classification
Other (Connective tissue), Extracellular matrix component, Not a receptor, enzyme, transporter, or classical molecular target
01

Overview

Fascia is an extensive network of connective tissue that envelops and supports all structures and organs throughout the human body—including muscles, nerves, blood vessels, tendons, ligaments, bones, and internal organs. It is composed primarily of collagen fibers interspersed with elastin fibers within an extracellular matrix rich in hyaluronan (hyaluronic acid) and proteoglycans. This structure provides both strength and flexibility while enabling smooth gliding between adjacent tissues. There are several types of fascia: - **Superficial fascia**, located just beneath the skin; - **Deep fascia**, which surrounds muscles/bones/tendons/nerves; - **Visceral fascia**, supporting internal organs; - **Parietal fascia**, lining body cavities. The main cellular components include fibroblasts (which produce collagen), myofibroblasts (with contractile properties), adipocytes (fat storage), fasciacytes (produce hyaluronic acid), telocytes (cellular communication), macrophages/mast cells/other immune cells[2][5][7]. Functionally, the fascial system maintains structural integrity by distributing mechanical forces across the body during movement while reducing friction between moving parts. It also plays roles in joint stability/circulation/shock absorption/intercellular signaling. While crucial for normal physiology—and implicated secondarily in conditions like chronic pain syndromes or fibrosis—fascia itself is not considered a classical therapeutic "target" such as receptors or enzymes would be.[1][2][3] Fascia is *not* a single molecule/receptor/enzyme/transporter but rather an anatomical structure/system made up primarily of extracellular matrix proteins—mainly collagen—and various cell types embedded within it.[1] Therefore: - It does *not* fit standard definitions for drug targets used in pharmacology/therapeutics. - No canonical abbreviation exists beyond its full name ("fascia"). - No direct interacting drugs/mechanisms/biomarkers/safety concerns apply at the molecular level. If you are seeking information about specific molecules within the fascial system—such as particular collagens or cell surface receptors expressed by fibroblasts—please specify further so that structured data can be provided at that level.

Other names
Connective tissue networkfascial systemfascial tissuefasciae (plural)
02

Mechanism of action

Not applicable; no known drugs directly target fascia as a molecule.

03

Biological functions

Structural support and protection of organs and tissuesReduction of friction between tissuesTransmission and distribution of mechanical stressStabilization of body structures and jointsFacilitation of movement by allowing muscles/organs to glide smoothly
04

Disease associations

Inflammation (e.g., fasciitis)Chronic pain syndromes (e.g., myofascial pain syndrome)Fibrosis/scarring disordersLimited role in direct disease causation; more often involved in secondary pathology due to trauma or inflammation
05

Safety considerations

Not applicable as a therapeutic target.Surgical manipulation can cause scarring/adhesion formation.Inflammation can lead to restricted movement/pain.
06

Interacting drugs

None specific; not a druggable molecular target. Some drugs may affect fascia indirectly via anti-inflammatory or anti-fibrotic mechanisms.
07

Biomarkers

None specific for patient selection or efficacy monitoring related to "fascia" as a molecular entity.

Beyond the preview

Go deeper on Fascia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fascia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call